Randomized clinical trials in gastrointestinal stromal tumors.

ABSTRACT: Gastrointestinal (GI) stromal tumor (GIST) is the most common mesenchymal tumor of the GI tract, constituting 80% of all GI mesenchymal tumors and approximately 20% of all small bowel malignancies, excluding lymphomas. This article provides a summary of recent randomized clinical trials of these tumors.

SUBMITTER: Learn PA 

PROVIDER: S-EPMC3164338 | biostudies-literature | 2010 Jan

REPOSITORIES: biostudies-literature